Vincerx Pharma Inc. (VINC)
NASDAQ: VINC
· Real-Time Price · USD
0.05
-0.00 (-1.96%)
At close: Jun 09, 2025, 12:40 PM
Vincerx Pharma Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.09 | -0.31 | -5.32 | -24.47 | -50.36 | -25.52 | -11.1 | -12.4 | -8.11 | -19.75 | -8.63 | -8.05 | -37.24 | -164.07 | -58.33 | -522.09 | -211.19 |
PEG Ratio | 0.00 | -0.00 | -0.02 | 0.34 | -0.33 | 0.51 | 0.96 | 0.66 | -0.06 | 0.29 | 3.54 | -0.16 | -0.5 | 2.11 | -0.06 | 7.06 | 2.75 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | 384.49 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 41.75K |
PB Ratio | 0.92 | 3.67 | 18.32 | 11.45 | -4.03K | 45.02 | 27.39 | 22.92 | 12.79 | 9.05 | 9.75 | 7.45 | 18.75 | 42.34 | 56.87 | 59.33 | 207.48 |
P/FCF Ratio | -0.43 | -1.62 | -26.15 | -30.36 | -323.53 | -63 | -64.89 | -43.56 | -33.66 | -31.21 | -39.13 | -34.89 | -111.24 | -369.53 | -554.16 | -505.5 | -628.39 |
P/OCF Ratio | -0.43 | -1.62 | -26.15 | -30.36 | -323.53 | -63 | -64.89 | -43.56 | -33.66 | -31.21 | -39.13 | -34.89 | -111.24 | -369.79 | -555.34 | -519.6 | -1.54K |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | -6.1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -27.06 |
Debt / Equity Ratio | n/a | n/a | 0.18 | 0.13 | -3.57 | 0.22 | 0.18 | 0.13 | 0.10 | 0.07 | 0.06 | 0.05 | 0.05 | 0.04 | 0.04 | 0.06 | 0.13 |
Quick Ratio | 1.79 | 1.21 | 2.17 | 3.43 | 0.72 | 2.63 | 2.54 | 3.56 | 4.11 | 6.25 | 6.76 | 7.88 | 8.51 | 8.04 | 4.90 | 5.52 | 1.87 |
Current Ratio | 1.79 | 1.21 | 2.17 | 3.43 | 0.72 | 2.63 | 2.58 | 3.47 | 4.11 | 6.11 | 6.76 | 7.88 | 8.51 | 8.04 | 4.90 | 5.52 | 1.87 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | 0.07 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | -7.3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -2.42 | -2.93 | -0.86 | -0.12 | 19.98 | -0.44 | -0.62 | -0.46 | -0.39 | -0.11 | -0.28 | -0.23 | -0.13 | -0.06 | -0.24 | -0.03 | -0.25 |
Return on Assets | -1.07 | -1 | -0.52 | -0.08 | -1.12 | -0.27 | -0.37 | -0.32 | -0.29 | -0.09 | -0.23 | -0.2 | -0.11 | -0.05 | -0.19 | -0.02 | -0.11 |
Return on Invested Capital | -1.61 | -3.15 | -0.72 | -0.42 | -2.68 | -0.49 | -0.53 | -0.4 | -0.37 | -0.12 | -0.26 | -0.23 | -0.16 | 0.13 | -0.22 | 1.49 | -0.16 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | 0.80 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.00 |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | -3.77 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -49.42 |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | -3.77 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -49.42 |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | -4.21 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -75.79 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | -4.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -75.79 |